Kronox Lab Sciences profit and loss

Latest FY26

Revenue: ₹101cr+1.0% on FY25
EBITDA: ₹34.3cr+3.5% on FY25
Net profit: ₹27.7cr+9.3% on FY25
EPS: ₹7.51+8.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Expenses
	105	101	100	89.9
	5.6	5.2	2.5	1.6
	111	106	103	91.4
	49.4	47.1	48.7	44.9
	−0.4	−0.6	2.3	1.0
	7.6	7.4	4.8	6.2
	0.1	0.1	0.0	0.0
	2.1	2.0	1.4	1.3
	13.7	13.0	11.4	9.5
	72.4	69.1	68.4	62.8
	35.2	34.3	33.1	28.3
	33.1	32.2	31.7	27.0
Profit
	38.6	37.3	34.3	28.6
	38.6	37.3	34.3	28.6
	10.1	9.7	8.9	7.3
	−0.1	−0.1	0.1	−0.1
	10.0	9.6	9.0	7.3
	28.6	27.7	25.3	21.4
	28.6	27.7	25.3	21.4
	0.2	0.2	0.2	0.2
	28.7	27.9	25.5	21.6
Per share
	₹7.79	₹7.51	₹6.91	₹5.81
	₹7.79	₹7.51	₹6.91	₹5.81
Other comprehensive income — detail
	0.2	0.2	0.2	—
	−0.2	−0.2	−0.2	—
	—	—	—	−0.2
	−0.0	0.0	0.0	—
Per share — as-filed variants
	₹7.79	₹7.51	₹6.91	₹5.81
	₹7.79	₹7.51	₹6.91	₹5.81
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	56.4	54.6	49.3	44.0
	53.6%	54.0%	49.2%	49.0%
Adjusted (ex-exceptional items) — derived
	38.6	37.3	34.3	28.6
	28.6	27.7	25.3	21.4
	₹7.79	₹7.51	₹6.91	₹5.81

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KRONOX₹194.73

Kronox Lab Sciences Limited

· Chemicals

Annual Quarterly₹ CrorePeersJAYAGROGN DMCC SRHHYPOLTD CHEMFAB PRIMO PLASTIBLEN GEMAROMA SUDARCOLORMcap ₹723 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	89.9	100.2	101.2	105.3
Other Income	1.6	2.5	5.2	5.6
Total Income	91.4	102.7	106.4	110.9
Expenses
+ Cost of Materials Consumed	44.9	48.7	47.1	49.4
+ Changes in Inventories	1.0	2.3	-0.6	-0.4
+ Employee Benefit Expense	6.2	4.8	7.4	7.6
+ Finance Costs	0.0	0.0	0.1	0.1
+ Depreciation & Amortisation	1.3	1.4	2.0	2.1
+ Other Expenses	9.5	11.4	13.0	13.7
Total Expenses	62.8	68.4	69.1	72.4
EBITDA	28.3	33.1	34.3	35.2
EBIT	27.0	31.7	32.2	33.1
Profit
PBT before Exceptional Items	28.6	34.3	37.3	38.6
Pretax Income	28.6	34.3	37.3	38.6
+ Current Tax	7.3	8.9	9.7	10.1
+ Deferred Tax	-0.1	0.1	-0.1	-0.1
Tax Expense	7.3	9.0	9.6	10.0
Net Income	21.4	25.3	27.7	28.6
+ Net Income — Continuing Ops	21.4	25.3	27.7	28.6
+ Other Comprehensive Income	0.2	0.2	0.2	0.2
Total Comprehensive Income	21.6	25.5	27.9	28.7
Per Share
Basic EPS	5.81	6.91	7.51	7.79
Diluted EPS	5.81	6.91	7.51	7.79
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	0.2	0.2	0.2
+ Tax on Items NOT to be Reclassified	—	-0.2	-0.2	-0.2
+ Tax on Items NOT to be Reclassified — alt tag	-0.2	—	—	—
+ Tax on Items to be Reclassified	—	0.0	0.0	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	5.81	6.91	7.51	7.79
Diluted EPS — Continuing Operations	5.81	6.91	7.51	7.79
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	44.0	49.3	54.6	56.4
Gross Margin %	48.97	49.18	53.99	53.56
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	28.6	34.3	37.3	38.6
Net Income Adj (tax-effected)	21.4	25.3	27.7	28.6
EPS Adj	5.81	6.91	7.51	7.79
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00
Paid Up Equity Capital	3,71,040.0	37.1	37.1	37.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.